Blog
Should You Delay Your Social Security Claim Age? The Data Is Abundantly Clear for Retirees
Social Security retirement benefits are important to understand in terms of financial security. What some may not realize is that the timing of when to begin claiming these benefits is a
7 Billionaires Are Betting Big on This Quantum Computing Powerhouse -- and It's Not IonQ or D‑Wave
Do you want to know the best way to invest in the next big thing? Looking at what the so-called "smart money" is doing is a great place to start.
Quantum computing certainly deserves a spot on the
Kevin Warsh Heading the Fed Could Trigger Big Market Moves -- Here's How Investors Should Prepare
Kevin Warsh, President Trump's pick to head the Federal Reserve, is poised to take the baton from current Fed chair Jerome Powell on May 15, 2026. He will move into a position that holds tremendous
Bad News for Tesla Shareholders: Should You Sell the Stock?
Tesla (NASDAQ: TSLA) is one of the leading electric vehicle (EV) makers in the world and a pioneer in the industry, but the stock's long-term thesis has shifted to other ventures, including its
Retirees Who Delay Social Security Get 1 Hidden Advantage
There's a reason financial experts often encourage retirees to delay claiming Social Security if they can afford to wait. Waiting to file for benefits could boost your monthly checks for life.
You
Prediction: This Could Be Nvidia's Stock Price By the End of 2027
Since early 2023, Nvidia (NASDAQ: NVDA) has been one of the undisputed beneficiaries of the mad dash to adopt artificial intelligence (AI). The company's graphics processing units (GPUs) -- which
Worried About a Stock Market Crash? The Best Energy Stocks to Buy Right Now
There's no doubt about it: markets are volatile, and investors are nervous.
Equity valuations are near the highest levels seen in decades, interest rates are still elevated, and geopolitical tension
These Are the 10 Largest Consumer Staples Stocks in May -- How to Pick the Top Investments
As artificial intelligence (AI) disrupts industries from software to financial management, the idea of owning shares of companies that make and sell tangible products that everyday people need
This Beaten-Down Chip Stock Just Did Something It Hasn't Done in a Year. Time to Buy?
Chip stocks have made a nice recovery over the past several weeks, with most climbing out of the red and into the black for the year. Generally, it has been a case of investors buying back in after
Atlanticus (ATLC) Q1 2026 Earnings Transcript
Image source: The Motley Fool.
Thursday, May 7, 2026 at 5 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Down 40%, Is It Time To Buy MercadoLibre?
MercadoLibre (NASDAQ: MELI) has been a top stock throughout its history as it's built Latin America's largest e-commerce and digital payments business.
However, more recently, the company has come
PCJ Investment Counsel Cashes Out of $10.5 Million MEOH Position
According to a recent SEC filing dated May 11, 2026, PCJ Investment Counsel liquidated its entire holding in Methanex (NASDAQ:MEOH), by selling 208,630 shares. The estimated transaction value is
Up 377%, Is Intel Proving Why It Was a Mistake for Nvidia to Replace Intel in the Dow Jones Industrial Average?
When Intel (NASDAQ: INTC) was added to the Dow Jones Industrial Average (DJINDICES: ^DJI) in November 1999, it was a sign of the tech industry's rising importance to the U.S. stock market -- Intel
Fuel Shortages Could Hit This Summer and Oil Execs Say Recovery Is Months Away. 3 Stocks to Own While It Lasts.
The world is still highly reliant on oil and natural gas despite the global effort to go green. The geopolitical conflict in the Middle East has left the world short 1 billion barrels of oil
Too Many Tech Stocks Lurking in Your Portfolio? These 3 Investments Offer More Balance.
For some investors, 2026 has been a wake-up call that they have too many tech stocks lurking in their portfolio. Without sufficient diversification, there's little to absorb the shocks of financial
Halozyme (HALO) Q1 2026 Earnings Transcript
Image source: The Motley Fool.
Monday, May 11, 2026 at 4:30 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Anthropic Just Delivered Great News for Alphabet Investors
Recent reports from The Information suggest that Anthropic, the artificial intelligence (AI) company behind Claude, has committed $200 billion over five years to Google Cloud for additional compute
Traeger (COOK) Q1 2026 Earnings Transcript
Image source: The Motley Fool.
Monday, May 11, 2026 at 4:30 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Archer (ACHR) Q1 2026 Earnings Call Transcript
Image source: The Motley Fool.
Monday, May 11, 2026 at 5 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
GoPro GPRO Q1 2026 Earnings Call Transcript
Image source: The Motley Fool.
Monday, May 11, 2026 at 5 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Best Fintech Stocks to Buy in 2026
Fintech stocks combine fast-growing tech platforms with financial products and have produced compelling opportunities that have outperformed the S&P 500.
Mordor Intelligence projects a 15.3%
ESTA Founder Sells $7.9M on Earnings Day — Here's Why that's Not the Story
On May 6, 2026, Founder and former CEO Juan José Chacón Quirós, now serving as a director and paid consultant, reported the indirect sale of 105,000 shares of Establishment Labs Holdings Inc. (NASDA
Babcock & Wilcox (BW) Q1 2026 Earnings Transcript
Image source: The Motley Fool.
May 11, 2026
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Simon (SPG) Q1 2026 Earnings Call Transcript
Image source: The Motley Fool.
Monday, May 11, 2026 at 5 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Is Bristol Myers Squibb Stock Overvalued at Nearly $60? A Reality Check for Value Investors.
Bristol Myers Squibb's (NYSE: BMY) shares are trading for a bit less than $60 apiece, which may seem like an affordable price to pay for a pharmaceutical company of its stature. But some would argue